So a scientist walks into a bar...
The Old Ox Brewery to be more specific. And then shares their work with the public. Over beers. Alright, its not much of a punchline, but it does make for a good time. Check here for upcoming events!
Tuesday, DEC 4
THE BOMB DETECTIVE
OLD OX BREWERY, 6:30 - 7:30 p.m.
44652 Guilford Drive, Suite 114
Ashburn, VA 20147
After a terrorist's bomb goes off, the race to put it back together begins and it's usually led by KIRK YEAGER. As the FBI's Chief Explosives Scientist, he leads U.S. and foreign law enforcement to determine how terrorist-made explosives work and finds new ways to detect and stop them. Meet Kirk Yeager for a discussion of his work as a chemist, engineer, and one of the FBI's five senior laboratory scientists.
* To request reasonable accommodation for a disability, call 703-777-0368. Three days' notice is requested.
Tuesday, Nov 13
THE BIOLOGY OF SELF
NELSON SPRUSTON, a Senior Director at the Janelia Research Campus, examines humankind’s pursuit to understand the nature of self – from the philosophical discussions in Ancient Greece to the modern concepts of neuroscience that unveil the biological basis of self.
Tuesday, OCT 13
THE DARK WEB
You’ve heard about it, but do you really know what it is? This talk will shed light on the darkest corners of the internet. WARREN HOLSTON has worked throughout the intelligence and defense community for more than 30 years. He has served as collection officer and senior manager in the Central Intelligence Agency and as a manhunting expert for U.S. Special Operations Command. Holston has managed and conducted counterterrorism, covert action and technical operations worldwide.
Tuesday, SEPT 11
TALES FROM A DRUG DEVELOPER
Developing pharmaceutical drugs to treat human diseases is a challenging and expensive process. Although huge strides have been made in the industry, drugs typically come with several warnings and side effects, and numerous diseases have no treatment at all. In this discussion about pharmaceutical drug discovery, BRUCE KIMMEL, CEO of Vidrio Technologies, reveals how drugs are developed and why we don’t have a cure for everything.